How much clot remains after minimally invasive surgery for spontaneous intracerebral hemorrhage may help explain why some patients recover function better than others, but a new systematic review and meta-analysis finds the evidence too thin to settle the question. The study, published in the journal Neurocritical Care, pooled prognostic data from studies that related residual or end-of-treatment hematoma burden to clinical outcomes in adults treated with minimally invasive evacuation. Its central result: each additional milliliter of residual blood was directionally associated with lower odds of a favorable functional outcome, yet the primary estimate crossed the null, with an odds ratio of 0.946 (95% confidence interval 0.879–1.018).
The research team, led by Chen Guo, Chong Zhang and Xiao-Bin Zhang, searched Embase, Web of Science, the Cochrane Library and PubMed through 10 May 2026 without language or year restrictions. From 881 records, 62 reports were included qualitatively. Twelve underwent quantitative extractability review, ten contributed quantitative evidence or audit rows, but only three independent studies entered the exploratory continuous model — a strikingly small foundation for a question that matters to surgeons and trialists alike. The review was prospectively registered in PROSPERO (CRD420261399487).
Methodologically, the analysis prioritized adjusted continuous prognostic estimates. The primary inference used random-effects inverse-variance meta-analysis of log odds ratios with restricted maximum likelihood and Hartung–Knapp adjustment, yielding the non-significant pooled estimate and an approximate prediction interval of 0.69–1.29, which signals substantial uncertainty about what a new study might find. The modified Rankin Scale 0–3 outcome analysis included only two studies, and heterogeneous threshold evidence was summarized narratively rather than pooled into a single effect size.
The authors’ conclusion is deliberately cautious. Smaller residual or end-of-treatment hematoma volume was directionally associated with better functional outcome, they report, but the primary estimate was not statistically significant, and the current evidence does not validate a universal cutoff or establish residual volume as a causal treatment target. Future trials, they argue, should adopt common imaging and outcome data elements so that end-of-treatment volume–outcome associations can be tested rigorously, and so the volume’s potential role as a technical success measure in minimally invasive evacuation can be properly evaluated. Until then, the intuitive idea that leaving less clot behind helps patients recover remains an unproven — though plausible — hypothesis rather than an evidence-backed standard.
Subject of Research: The association between residual hematoma volume after minimally invasive evacuation and outcomes in spontaneous intracerebral hemorrhage
Article Title: Systematic Review and Prognostic-Factor Meta-analysis of Residual or End-of-Treatment Hematoma Burden after Minimally Invasive Evacuation for Spontaneous Intracerebral Hemorrhage
Article References: Guo, C., Zhang, C., & Zhang, X.-B. (2026). Systematic Review and Prognostic-Factor Meta-analysis of Residual or End-of-Treatment Hematoma Burden after Minimally Invasive Evacuation for Spontaneous Intracerebral Hemorrhage. Neurocritical Care. https://doi.org/10.1007/s12028-026-02703-z
Image Credits: AI Generated
DOI: 10.1007/s12028-026-02703-z
Keywords: intracerebral hemorrhage, minimally invasive evacuation, hematoma volume, systematic review, meta-analysis, functional outcome, prognosis, neurocritical care, stroke, modified Rankin Scale, Systematic, Review
News Source: Cassandra Pierce. (October 29, 2026). Residual Hematoma Volume After Stroke Evacuation Uncertain Predictor of Recovery. Scienmag.
